Omega Funds Fund IX

About Omega Funds Fund IX

Life Sciences, Biotech, Healthtech, Oncology focused fund

Investment Focus

Location / RegionUnited States

Funding StageGrowth

Industry Focus

Biotech

Digital Health

Therapeutics

Investor Signals Profile

active

Sweet Spot

Science-driven founder building medicine products for patients

life sciences

biotech/pharma

healthcare

Europe-linked

platform investing

Bullish Signals

53 products brought to patientsexternal

1 IPO + 8 acquisitions in portfolioexternal

Advisor to European funds — broad reachexternal

Team: experience, commitment, connectionswebsite

GP vocal on EU biotech gaplinkedin

Stampacchia featured on The Long Run podcastlinkedin

Contrarian Signals

European fund advisory — complex structureexternal

No GP info publicly listedexternal

EU ecosystem gaps — harder portfolio buildinglinkedin

Founder Do's

Be science-driven, patient-focused

Show clear path to patients

Leverage Omega's network & connections

Come prepared — luck favors prepared minds

Think long-term company building, not just science

Founder Don'ts

Don't pitch without strong scientific basis

Avoid non-healthcare verticals

Don't expect passive investor

Key GPs & Partners

Otello Stampacchia

Partner

science-firstEurope advocatethought leader

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size$647M

Saves0

Website

Key People

Otello Stampacchia, Francesco Draetta, Claudio Nessi

Otello StampacchiaPartner